Extended Data Table 2 Placebo-Corrected Treatment Difference at Month 30 with and without Imputation for Missing Data for Selected Echocardiographic Variables in the Overall Population

From: Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trial

  1. a’ – peak late diastolic mitral annular tissue velocity, e’ – peak early diastolic mitral annular tissue velocity, E wave – peak early diastolic transmitral flow velocity, LV – left ventricular, LVEF – left ventricular ejection fraction, s’ – peak systolic mitral annular tissue velocity, TDI – tissue Doppler imaging.
Back to article page